133 related articles for article (PubMed ID: 30334393)
1. Light-activatable cannabinoid prodrug for combined and target-specific photodynamic and cannabinoid therapy.
Ling X; Zhang S; Liu Y; Bai M
J Biomed Opt; 2018 Oct; 23(10):1-9. PubMed ID: 30334393
[TBL] [Abstract][Full Text] [Related]
2. Quantitative modeling of the dynamics and intracellular trafficking of far-red light-activatable prodrugs: implications in stimuli-responsive drug delivery system.
Li M; Thapa P; Rajaputra P; Bio M; Peer CJ; Figg WD; You Y; Woo S
J Pharmacokinet Pharmacodyn; 2017 Dec; 44(6):521-536. PubMed ID: 28913666
[TBL] [Abstract][Full Text] [Related]
3. Light-activatable dual-source ROS-responsive prodrug nanoplatform for synergistic chemo-photodynamic therapy.
Yang B; Wang K; Zhang D; Sun B; Ji B; Wei L; Li Z; Wang M; Zhang X; Zhang H; Kan Q; Luo C; Wang Y; He Z; Sun J
Biomater Sci; 2018 Nov; 6(11):2965-2975. PubMed ID: 30255178
[TBL] [Abstract][Full Text] [Related]
4. A tumor-targeted activatable phthalocyanine-tetrapeptide-doxorubicin conjugate for synergistic chemo-photodynamic therapy.
Ke MR; Chen SF; Peng XH; Zheng QF; Zheng BY; Yeh CK; Huang JD
Eur J Med Chem; 2017 Feb; 127():200-209. PubMed ID: 28063352
[TBL] [Abstract][Full Text] [Related]
5. Silicon Phthalocyanines Axially Disubstituted with Erlotinib toward Small-Molecular-Target-Based Photodynamic Therapy.
Chen JJ; Huang YZ; Song MR; Zhang ZH; Xue JP
ChemMedChem; 2017 Sep; 12(18):1504-1511. PubMed ID: 28776965
[TBL] [Abstract][Full Text] [Related]
6. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy.
Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y
Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794
[TBL] [Abstract][Full Text] [Related]
7. Far-Red Light-Activatable Prodrug of Paclitaxel for the Combined Effects of Photodynamic Therapy and Site-Specific Paclitaxel Chemotherapy.
Thapa P; Li M; Bio M; Rajaputra P; Nkepang G; Sun Y; Woo S; You Y
J Med Chem; 2016 Apr; 59(7):3204-14. PubMed ID: 26974508
[TBL] [Abstract][Full Text] [Related]
8. Smart activatable and traceable dual-prodrug for image-guided combination photodynamic and chemo-therapy.
Hu F; Yuan Y; Mao D; Wu W; Liu B
Biomaterials; 2017 Nov; 144():53-59. PubMed ID: 28823843
[TBL] [Abstract][Full Text] [Related]
9. Multilayer photodynamic therapy for highly effective and safe cancer treatment.
Yang L; Zhang S; Ling X; Shao P; Jia N; Bai M
Acta Biomater; 2017 May; 54():271-280. PubMed ID: 28285077
[TBL] [Abstract][Full Text] [Related]
10. Combined CB2 receptor agonist and photodynamic therapy synergistically inhibit tumor growth in triple negative breast cancer.
Zhang J; Zhang S; Liu Y; Su M; Ling X; Liu F; Ge Y; Bai M
Photodiagnosis Photodyn Ther; 2018 Dec; 24():185-191. PubMed ID: 30240926
[TBL] [Abstract][Full Text] [Related]
11. Light-Activatable Red Blood Cell Membrane-Camouflaged Dimeric Prodrug Nanoparticles for Synergistic Photodynamic/Chemotherapy.
Pei Q; Hu X; Zheng X; Liu S; Li Y; Jing X; Xie Z
ACS Nano; 2018 Feb; 12(2):1630-1641. PubMed ID: 29346736
[TBL] [Abstract][Full Text] [Related]
12. NIR-Light-Activated Combination Therapy with a Precise Ratio of Photosensitizer and Prodrug Using a Host-Guest Strategy.
Chen H; Zeng X; Tham HP; Phua SZF; Cheng W; Zeng W; Shi H; Mei L; Zhao Y
Angew Chem Int Ed Engl; 2019 Jun; 58(23):7641-7646. PubMed ID: 30980463
[TBL] [Abstract][Full Text] [Related]
13. Target-selective phototherapy using a ligand-based photosensitizer for type 2 cannabinoid receptor.
Zhang S; Jia N; Shao P; Tong Q; Xie XQ; Bai M
Chem Biol; 2014 Mar; 21(3):338-44. PubMed ID: 24583052
[TBL] [Abstract][Full Text] [Related]
14. A cyclodextrin dimer with a photocleavable linker as a possible carrier for the photosensitizer in photodynamic tumor therapy.
Ruebner A; Yang Z; Leung D; Breslow R
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14692-3. PubMed ID: 10611274
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D
ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
[TBL] [Abstract][Full Text] [Related]
16. Glutathione-depleting polyprodrug nanoparticle for enhanced photodynamic therapy and cascaded locoregional chemotherapy.
Zhang X; Zhang X; Chen S; Liu Y; Cao C; Cheng G; Wang S
J Colloid Interface Sci; 2024 Sep; 670():279-287. PubMed ID: 38763024
[TBL] [Abstract][Full Text] [Related]
17. A tumor-targeted Ganetespib-zinc phthalocyanine conjugate for synergistic chemo-photodynamic therapy.
Huang L; Wei G; Sun X; Jiang Y; Huang Z; Huang Y; Shen Y; Xu X; Liao Y; Zhao C
Eur J Med Chem; 2018 May; 151():294-303. PubMed ID: 29627724
[TBL] [Abstract][Full Text] [Related]
18. Nanobody-Targeted Photodynamic Therapy Selectively Kills Viral GPCR-Expressing Glioblastoma Cells.
De Groof TWM; Mashayekhi V; Fan TS; Bergkamp ND; Sastre Toraño J; van Senten JR; Heukers R; Smit MJ; Oliveira S
Mol Pharm; 2019 Jul; 16(7):3145-3156. PubMed ID: 31244224
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of new 5-aminolevulinic acid derivatives as prodrugs of protoporphyrin for photodynamic therapy.
Zhu W; Gao YH; Song CH; Lu ZB; Namulinda T; Han YP; Yan YJ; Wang LX; Chen ZL
Photochem Photobiol Sci; 2017 Nov; 16(11):1623-1630. PubMed ID: 28933502
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of the photokilling effect of aluminum phthalocyanine in photodynamic therapy by conjugating with nitrogen-doped TiO2 nanoparticles.
Pan X; Xie J; Li Z; Chen M; Wang M; Wang PN; Chen L; Mi L
Colloids Surf B Biointerfaces; 2015 Jun; 130():292-8. PubMed ID: 25935263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
